Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells
Abstract
:1. Introduction
2. Results
2.1. Cisplatin Therapy Elicited the Formation of Giant Cells in Mice
2.2. Cisplatin Induced the Formation of Giant Cells in Melanoma Cells In Vitro
2.3. Giant Cells Exhibited Enlarged Volumes and Nuclei and Reduced Thicknesses and Motilities
2.4. Giant Cells Expressed the Cancer Stemness Markers ABCB5 and CD133 In Vitro and In Vivo
2.5. Giant Cells Retained Their Proliferating Potential but Were Not Senescence
2.6. Giant Cells Exhibited Enhanced Drug Resistance
2.7. Elevated Mitochondrial Activities and ATP Synthesis in Cisplatin-Induced Giant Cells
2.8. Metabolic Blockers Abolished the Cisplatin-Induced Formation of Giant Cells and Expression of Cancer Stemness Markers
3. Discussion
4. Materials and Methods
4.1. Reagents and Antibodies
4.2. Cell Culture
4.3. Tumor Growth In Vivo
4.4. Tissue Staining and Cellular Area Measurement
4.5. Time-Lapse Video-Micrography for the Recording of the Formation of Giant Cells
4.6. Immunofluorescence and Cell Morphology Staining
4.7. Mitochondrial Staining
4.8. Mitochondrial Membrane Potential
4.9. Measurement of Intracellular ATP Content
4.10. Western Blot Analysis
4.11. Quantitative Reverse-Transcription Polymerase Chain Reaction (qRT-PCR)
4.12. Flow Cytometric Analysis of Protein Expression, Multidrug Resistance (MDR), and Cell Size
4.13. Colony Formation Assays
4.14. Statistical Analysis
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Conflicts of Interest
Abbreviations
ABC | ATP-binding cassette |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 |
FSC | forward scatter |
MDR | multidrug resistance |
P-gp | P-glycoprotein |
SA-gal | senescence associated-β galactosidase |
SSC | side scatter |
References
- Jerant, A.F.; Johnson, J.T.; Sheridan, C.D.; Caffrey, T.J. Early detection and treatment of skin cancer. Am. Family Phys. 2000, 62, 357–368, 375–376, 381–382. [Google Scholar]
- Arozarena, I.; Wellbrock, C. Phenotype plasticity as enabler of melanoma progression and therapy resistance. Nat. Rev. Cancer 2019, 19, 377–391. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Soengas, M.S.; Lowe, S.W. Apoptosis and melanoma chemoresistance. Oncogene 2003, 22, 3138–3151. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jemal, A.; Thomas, A.; Murray, T.; Thun, M. Cancer statistics, 2002. CA Cancer J. Clin. 2002, 52, 23–47. [Google Scholar] [CrossRef]
- Siddik, Z.H. Cisplatin: Mode of cytotoxic action and molecular basis of resistance. Oncogene 2003, 22, 7265–7279. [Google Scholar] [CrossRef] [Green Version]
- Jamieson, E.R.; Lippard, S.J. Structure, Recognition, and Processing of Cisplatin-DNA Adducts. Chem. Rev. 1999, 99, 2467–2498. [Google Scholar] [CrossRef]
- Lockhart, A.C.; Tirona, R.G.; Kim, R.B. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol. Cancer Ther. 2003, 2, 685–698. [Google Scholar]
- Ghosh, S. Cisplatin: The first metal based anticancer drug. Bioorg. Chem. 2019, 88, 102925. [Google Scholar] [CrossRef]
- Chen, S.H.; Chang, J.Y. New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment. Int. J. Mol. Sci. 2019, 20, 4136. [Google Scholar] [CrossRef] [Green Version]
- Gottesman, M.M.; Fojo, T.; Bates, S.E. Multidrug resistance in cancer: Role of ATP-dependent transporters. Nat. Rev. Cancer 2002, 2, 48–58. [Google Scholar] [CrossRef] [Green Version]
- Huang, Y.; Anderle, P.; Bussey, K.J.; Barbacioru, C.; Shankavaram, U.; Dai, Z.; Reinhold, W.C.; Papp, A.; Weinstein, J.N.; Sadee, W. Membrane transporters and channels: Role of the transportome in cancer chemosensitivity and chemoresistance. Cancer Res. 2004, 64, 4294–4301. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Schatton, T.; Murphy, G.F.; Frank, N.Y.; Yamaura, K.; Waaga-Gasser, A.M.; Gasser, M.; Zhan, Q.; Jordan, S.; Duncan, L.M.; Weishaupt, C.; et al. Identification of cells initiating human melanomas. Nature 2008, 451, 345–349. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Frank, N.Y.; Pendse, S.S.; Lapchak, P.H.; Margaryan, A.; Shlain, D.; Doeing, C.; Sayegh, M.H.; Frank, M.H. Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter. J. Biol. Chem. 2003, 278, 47156–47165. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Massi, D.; Landriscina, M.; Piscazzi, A.; Cosci, E.; Kirov, A.; Paglierani, M.; Di Serio, C.; Mourmouras, V.; Fumagalli, S.; Biagioli, M.; et al. S100A13 is a new angiogenic marker in human melanoma. Mod. Pathol. 2010, 23, 804–813. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ohsie, S.J.; Sarantopoulos, G.P.; Cochran, A.J.; Binder, S.W. Immunohistochemical characteristics of melanoma. J. Cutan. Pathol. 2008, 35, 433–444. [Google Scholar] [CrossRef] [PubMed]
- Garbe, C.; Leiter, U.; Ellwanger, U.; Blaheta, H.J.; Meier, F.; Rassner, G.; Schittek, B. Diagnostic value and prognostic significance of protein S-100beta, melanoma-inhibitory activity, and tyrosinase/MART-1 reverse transcription-polymerase chain reaction in the follow-up of high-risk melanoma patients. Cancer 2003, 97, 1737–1745. [Google Scholar] [CrossRef] [PubMed]
- Yin, A.H.; Miraglia, S.; Zanjani, E.D.; Almeida-Porada, G.; Ogawa, M.; Leary, A.G.; Olweus, J.; Kearney, J.; Buck, D.W. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997, 90, 5002–5012. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Weigmann, A.; Corbeil, D.; Hellwig, A.; Huttner, W.B. Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc. Natl. Acad. Sci. USA 1997, 94, 12425–12430. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rappa, G.; Fodstad, O.; Lorico, A. The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma. Stem Cells 2008, 26, 3008–3017. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kung, M.L.; Hsieh, C.W.; Tai, M.H.; Weng, C.H.; Wu, D.C.; Wu, W.J.; Yeh, B.W.; Hsieh, S.L.; Kuo, C.H.; Hung, H.S.; et al. Nanoscale characterization illustrates the cisplatin-mediated biomechanical changes of B16-F10 melanoma cells. Phys. Chem. Chem. Phys. 2016, 18, 7124–7131. [Google Scholar] [CrossRef] [PubMed]
- Gerdes, J.; Schwab, U.; Lemke, H.; Stein, H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int. J. Cancer 1983, 31, 13–20. [Google Scholar] [CrossRef]
- Frank, N.Y.; Margaryan, A.; Huang, Y.; Schatton, T.; Waaga-Gasser, A.M.; Gasser, M.; Sayegh, M.H.; Sadee, W.; Frank, M.H. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma. Cancer Res. 2005, 65, 4320–4333. [Google Scholar] [CrossRef] [Green Version]
- Cho, K.A.; Ryu, S.J.; Oh, Y.S.; Park, J.H.; Lee, J.W.; Kim, H.P.; Kim, K.T.; Jang, I.S.; Park, S.C. Morphological adjustment of senescent cells by modulating caveolin-1 status. J. Biol. Chem. 2004, 279, 42270–42278. [Google Scholar] [CrossRef] [Green Version]
- Van Deursen, J.M. The role of senescent cells in ageing. Nature 2014, 509, 439–446. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mosmann, T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55–63. [Google Scholar] [CrossRef]
- Liu, T.; Hannafon, B.; Gill, L.; Kelly, W.; Benbrook, D. Flex-Hets differentially induce apoptosis in cancer over normal cells by directly targeting mitochondria. Mol. Cancer Ther. 2007, 6, 1814–1822. [Google Scholar] [CrossRef] [Green Version]
- Bonnet, S.; Archer, S.L.; Allalunis-Turner, J.; Haromy, A.; Beaulieu, C.; Thompson, R.; Lee, C.T.; Lopaschuk, G.D.; Puttagunta, L.; Harry, G.; et al. A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007, 11, 37–51. [Google Scholar] [CrossRef] [Green Version]
- Luz, A.L.; Rooney, J.P.; Kubik, L.L.; Gonzalez, C.P.; Song, D.H.; Meyer, J.N. Mitochondrial Morphology and Fundamental Parameters of the Mitochondrial Respiratory Chain Are Altered in Caenorhabditis elegans Strains Deficient in Mitochondrial Dynamics and Homeostasis Processes. PLoS ONE 2015, 10, e0130940. [Google Scholar] [CrossRef] [PubMed]
- Pelicano, H.; Martin, D.S.; Xu, R.H.; Huang, P. Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25, 4633–4646. [Google Scholar] [CrossRef] [Green Version]
- Boyd, A.S.; Wu, H.; Shyr, Y. Monster cells in malignant melanoma. Am. J. Dermatopathol. 2005, 27, 208–210. [Google Scholar] [CrossRef] [PubMed]
- Sidhu, H.K.; Sidhu, J.S. Monster cells in malignant melanoma. Am. J. Dermatopathol. 2006, 28, 462–463. [Google Scholar] [CrossRef]
- Zhang, S.; Mercado-Uribe, I.; Xing, Z.; Sun, B.; Kuang, J.; Liu, J. Generation of cancer stem-like cells through the formation of polyploid giant cancer cells. Oncogene 2014, 33, 116–128. [Google Scholar] [CrossRef] [PubMed]
- Santamaria-Kisiel, L.; Rintala-Dempsey, A.C.; Shaw, G.S. Calcium-dependent and -independent interactions of the S100 protein family. Biochem. J. 2006, 396, 201–214. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gazzaniga, P.; Cigna, E.; Panasiti, V.; Devirgiliis, V.; Bottoni, U.; Vincenzi, B.; Nicolazzo, C.; Petracca, A.; Gradilone, A. CD133 and ABCB5 as stem cell markers on sentinel lymph node from melanoma patients. Eur. J. Surg. Oncol. J. Eur. Soc. Surg. Oncol. Br. Assoc. Surg. Oncol. 2010, 36, 1211–1214. [Google Scholar] [CrossRef]
- Ma, J.; Lin, J.Y.; Alloo, A.; Wilson, B.J.; Schatton, T.; Zhan, Q.; Murphy, G.F.; Waaga-Gasser, A.M.; Gasser, M.; Stephen Hodi, F.; et al. Isolation of tumorigenic circulating melanoma cells. Biochem. Biophys. Res. Commun. 2010, 402, 711–717. [Google Scholar] [CrossRef] [Green Version]
- Ye, X.Q.; Li, Q.; Wang, G.H.; Sun, F.F.; Huang, G.J.; Bian, X.W.; Yu, S.C.; Qian, G.S. Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells. Int. J. Cancer 2011, 129, 820–831. [Google Scholar] [CrossRef]
- Ye, X.Q.; Wang, G.H.; Huang, G.J.; Bian, X.W.; Qian, G.S.; Yu, S.C. Heterogeneity of mitochondrial membrane potential: A novel tool to isolate and identify cancer stem cells from a tumor mass? Stem Cell Rev. 2011, 7, 153–160. [Google Scholar] [CrossRef] [PubMed]
- Johnson, R.C.; Augustin-Voss, H.G.; Zhu, D.Z.; Pauli, B.U. Endothelial cell membrane vesicles in the study of organ preference of metastasis. Cancer Res. 1991, 51, 394–399. [Google Scholar]
- Liu, G.S.; Liu, L.F.; Lin, C.J.; Tseng, J.C.; Chuang, M.J.; Lam, H.C.; Lee, J.K.; Yang, L.C.; Chan, J.H.; Howng, S.L.; et al. Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: Involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway. Mol. Pharmacol 2006, 69, 440–451. [Google Scholar] [CrossRef]
- Brunt, K.R.; Tsuji, M.R.; Lai, J.H.; Kinobe, R.T.; Durante, W.; Claycomb, W.C.; Ward, C.A.; Melo, L.G. Heme oxygenase-1 inhibits pro-oxidant induced hypertrophy in HL-1 cardiomyocytes. Exp. Biol. Med. (Maywood) 2009, 234, 582–594. [Google Scholar] [CrossRef]
- Tai, M.H.; Weng, C.H.; Mon, D.P.; Hu, C.Y.; Wu, M.H. Ultraviolet C Irradiation Induces Different Expression of Cyclooxygenase 2 in NIH 3T3 Cells and A431 Cells: The Roles of COX-2 Are Different in Various Cell Lines. Int. J. Mol. Sci. 2012, 13, 4351–4366. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Tiberghien, F.; Loor, F. Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay. Anti-Cancer Drugs 1996, 7, 568–578. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Weng, C.-H.; Wu, C.-S.; Wu, J.-C.; Kung, M.-L.; Wu, M.-H.; Tai, M.-H. Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells. Int. J. Mol. Sci. 2020, 21, 7892. https://doi.org/10.3390/ijms21217892
Weng C-H, Wu C-S, Wu J-C, Kung M-L, Wu M-H, Tai M-H. Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells. International Journal of Molecular Sciences. 2020; 21(21):7892. https://doi.org/10.3390/ijms21217892
Chicago/Turabian StyleWeng, Chien-Hui, Chieh-Shan Wu, Jian-Ching Wu, Mei-Lang Kung, Ming-Hsiu Wu, and Ming-Hong Tai. 2020. "Cisplatin-Induced Giant Cells Formation Is Involved in Chemoresistance of Melanoma Cells" International Journal of Molecular Sciences 21, no. 21: 7892. https://doi.org/10.3390/ijms21217892